Literature DB >> 24034609

Host restriction factor screening: let the virus do the work.

Michael S Diamond1, John W Schoggins.   

Abstract

In this issue of Cell Host & Microbe, Varble et al. (2013) engineer a library of RNA viruses to express small interfering RNAs and couple this with the power of virus evolution and selection to screen for host genes that when silenced resulted in greater viral infection in vivo.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24034609      PMCID: PMC3856910          DOI: 10.1016/j.chom.2013.08.014

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  9 in total

1.  An in vivo RNAi screening approach to identify host determinants of virus replication.

Authors:  Andrew Varble; Asiel A Benitez; Sonja Schmid; David Sachs; Jaehee V Shim; Ruth Rodriguez-Barrueco; Maryline Panis; Marshall Crumiller; Jose M Silva; Ravi Sachidanandam; Benjamin R tenOever
Journal:  Cell Host Microbe       Date:  2013-09-11       Impact factor: 21.023

2.  A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.

Authors:  Hong Zhao; Wenyu Lin; Kattareeya Kumthip; Du Cheng; Dahlene N Fusco; Oliver Hofmann; Nikolaus Jilg; Andrew W Tai; Kaku Goto; Leiliang Zhang; Winston Hide; Jae Young Jang; Lee F Peng; Raymond T Chung
Journal:  J Hepatol       Date:  2011-08-31       Impact factor: 25.083

Review 3.  RNA viruses and the host microRNA machinery.

Authors:  Benjamin R tenOever
Journal:  Nat Rev Microbiol       Date:  2013-03       Impact factor: 60.633

4.  Systematic identification of type I and type II interferon-induced antiviral factors.

Authors:  Su-Yang Liu; David Jesse Sanchez; Roghiyh Aliyari; Sun Lu; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

5.  Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.

Authors:  Philippe Metz; Eva Dazert; Alessia Ruggieri; Johanna Mazur; Lars Kaderali; Artur Kaul; Ulf Zeuge; Marc P Windisch; Martin Trippler; Volker Lohmann; Marco Binder; Michael Frese; Ralf Bartenschlager
Journal:  Hepatology       Date:  2012-10-14       Impact factor: 17.425

6.  A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication.

Authors:  Dahlene N Fusco; Cynthia Brisac; Sinu P John; Yi-Wen Huang; Christopher R Chin; Tiao Xie; Hong Zhao; Nikolaus Jilg; Leiliang Zhang; Stephane Chevaliez; Daniel Wambua; Wenyu Lin; Lee Peng; Raymond T Chung; Abraham L Brass
Journal:  Gastroenterology       Date:  2013-02-24       Impact factor: 22.682

7.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

8.  The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.

Authors:  Abraham L Brass; I-Chueh Huang; Yair Benita; Sinu P John; Manoj N Krishnan; Eric M Feeley; Bethany J Ryan; Jessica L Weyer; Louise van der Weyden; Erol Fikrig; David J Adams; Ramnik J Xavier; Michael Farzan; Stephen J Elledge
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

9.  A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response.

Authors:  Jianqing Li; Steve C Ding; Hyelim Cho; Brian C Chung; Michael Gale; Sumit K Chanda; Michael S Diamond
Journal:  MBio       Date:  2013-06-18       Impact factor: 7.867

  9 in total
  2 in total

1.  Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx.

Authors:  Tae Gun Kang; Kee Woong Kwon; Kyungsoo Kim; Insuk Lee; Myeong Joon Kim; Sang-Jun Ha; Sung Jae Shin
Journal:  Nat Commun       Date:  2022-06-07       Impact factor: 17.694

Review 2.  Type I interferons in infectious disease.

Authors:  Finlay McNab; Katrin Mayer-Barber; Alan Sher; Andreas Wack; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.